Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toll-free vaccines?

Arthur M Krieg

    Nature Biotechnology
    |March 9, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity.

    Journal for immunotherapy of cancer·2025
    Same author

    Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.

    Cancer·2025
    Same author

    Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.

    Cancer cell·2024
    Same author

    Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers.

    Frontiers in oncology·2023
    Same author

    Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC.

    JTO clinical and research reports·2023
    Same author

    Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.

    Nucleic acid therapeutics·2022
    Same journal

    Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

    Nature biotechnology·2026
    Same journal

    Unlocking the chemical potential of filamentous fungi using prime editing.

    Nature biotechnology·2026
    Same journal

    A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

    Nature biotechnology·2026
    Same journal

    Prime editing for precise genome engineering and modulation of fungal metabolism.

    Nature biotechnology·2026
    Same journal

    Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

    Nature biotechnology·2026
    Same journal

    A retargeted recombinase for precise insertion of large DNA.

    Nature biotechnology·2026
    See all related articles